Hearing diagnostic devices and equipment are used for testing and evaluating hearing loss. These devices usually consist of an embedded hardware unit connected to a pair of headphones and a test subject feedback button, sometimes controlled by a standard personal computer. The main types of hearing diagnostic devices and equipment are otoacoustic emission (OAE), audiometer, otoscope, tympanometer, and others. Otoacoustic emissions (OAEs) are sounds of cochlear origin that are recorded by a microphone fitted into the ear canal. These are used for indications such as conductive hearing loss, sensorineural hearing loss, and combination hearing loss. The end-users involved are hospitals, clinics, personal use, and ambulatory care settings. The hearing diagnostic devices and equipment market research report is one of a series of new reports from The Business Research Company that provides hearing diagnostic devices and equipment market statistics, including hearing diagnostic devices and equipment industry global market size, regional shares, competitors with a hearing diagnostic devices and equipment market share, detailed hearing diagnostic devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the hearing diagnostic devices and equipment industry. This hearing diagnostic devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global hearing diagnostic devices and equipment market size will grow from $1.97 billion in 2022 to $2.2 billion in 2023 at a compound annual growth rate (CAGR) of 11.7%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The hearing diagnostic devices and equipment market size is expected to grow from $3.23 billion in 2027 at a CAGR of 10.1%. Growth in the hearing diagnostic and equipment market is attributed to the increasing number of hearing loss cases. This increased prevalence of hearing loss is due to noise pollution, hearing diseases, ototoxic medications, hereditary disorders, birth complications, and a rising geriatric population. According to World Health Organization (WHO), the hearing diagnostic device market is expected to make enormous advancements and investments in hearing diagnostic devices and equipment even as the number of affected individuals is expected to increase to 900 million by 2050 in the world. According to the National Institute on Deafness and Other communication, disorders states that approximately one in three people in the United States between the ages of 65 and 74 have hearing loss, and half of those older than 75 have difficulty hearing. Hence, the rising prevalence of hearing disorders and losses drives the hearing diagnostic devices and equipment market. The unaffordability of healthcare equipment in middle-income countries acts as a major factor hindering the development of the hearing diagnostic device and equipment market. The hearing diagnostic device and equipment market includes advanced technologies and devices for diagnosis, testing, and evaluating hearing loss. The financial inability of remote regions within these middle-income countries, lack of proper infrastructure and healthcare services may hinder the market growth. According to World Bank data, out of the total world population of 7 billion, 5 billion belong to middle-income countries. The hearing healthcare industry is evolving with continuous innovations in terms of technologies used. These technologies use modules like Transient evoked otoacoustic emissions (TEOAE), Distortion product otoacoustic emissions (DPOAE), and Auditory Brainstem Response (ABR). TEOAE is the module that is used for hearing diagnosis and are generated by reflection of traveling wave. DPOAE is used to track the progress of cochlear function in newborns. The ABR is another test used by audiologists to check the way hearing nerves of babies respond to sounds. For example, Maico has invested and recently launched a new product named easy screen with BERAphone that is a combination of ABR, TEOAE, and DPOAE that are used for response detection, reduces the workload, and test time. The European Commission adopted two new regulations for medical devices to enhance safety, take effective measures in the event of concerns, and improve traceability. These regulations provide the medical device manufacturers with a stronger mandate for assessment of medical devices by independent notified bodies, a unique identification number for improving traceability throughout the supply chain, availability of clinical data on devices, and provides a central database to provide patients, healthcare professionals and the public with comprehensive information on products. These rules will help manufacturers to meet the standards, safety requirements and to make better-informed decisions. Major players in the hearing diagnostic devices and equipment market are Natus Medical, Maico Diagnostics, Inventis, William Demant, Amplivox, Welch Allyn, Grason Stadler, Interacoustics, Rion, and Sivantos. North America was the largest region in the global hearing diagnostic devices and equipment market in 2022. Asia-Pacific was the second largest market in hearing diagnostic devices and equipment market. The regions covered in the global hearing diagnostic devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the hearing diagnostic devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The hearing diagnostic devices and equipment market consists of sales of otoacoustic emission (OAE), audiometer, otoscope, tympanometer, and other hearing diagnostic devices that are used for testing and evaluating the hearingloss. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global hearing diagnostic devices and equipment market is segmented - 1) By Type: Otoacoustic emission (OAE), Audiometer, Otoscope, Tympanometer, Other Types 2) By Indication: Conductive Hearing Loss, Sensorineural Hearing Loss, Combination Hearing Loss 3) By End User: Hospitals, Clinics, Personal Use, Ambulatory care settings

Hearing implants are surgically installed devices aimed at improving the hearing capability of a person suffering from severe or profound levels of hearing loss. The main types of hearing implants devices and equipment are cochlear implants, middle ear implants, bone conduction implants, and auditory brainstem implants. A cochlear implant is an electronic device that partially restores hearing. It is an option for people who have severe hearing loss from inner-ear damage and are no longer helped by using hearing aids. These are used by age groups such as adults and pediatrics. The various end-users are hospitals, ENT clinics, and ambulatory surgical centres. The hearing implants devices and equipment market research report is one of a series of new reports from The Business Research Company that provides hearing implants devices and equipment market statistics, including hearing implants devices and equipment industry global market size, regional shares, competitors with a hearing implants devices and equipment market share, detailed hearing implants devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the hearing implants devices and equipment industry. This hearing implants devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global hearing implants market size will grow from $3.95 billion in 2022 to $4.4 billion in 2023 at a compound annual growth rate (CAGR) of 11.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The hearing implants market size is expected to grow to $6.36 billion in 2027 at a CAGR of 9.7%. The aging population is increasing worldwide and loss of hearing is one of the most common age-related disorders in the aged above 60 years. As reported by United Nations, in 2020, there are 727 million people aged 65 years in the world and with the increasing geriatric population, the demand for hearing implants is expected to rise. Therefore, the increasing aging population is expected to drive the market for hearing implants in the future. The surgical procedure for implanting hearing implants is associated with various risks and is expected to restraint the market growth in the future. During the surgery, there are possibilities of facial nerve damage which can lead to complete or partial paralysis on the same side of the face as the implant. Due to this and other complications such as the development of meningitis, cerebrospinal fluid leakage, infection, and others, people prefer conventional hearing aids over implants. Hence, restraining the growth of the hearing implants market. Companies in the hearing implants market are making implants using 3D printing in binaural cochlear surgeries. The technology focuses on developing customized 3D printed implants using biocompatible materials to treat anatomical defects with the help of stem cells. Sonova manufactures binaural cochlear implants, which use two different modes of stimulation, electrical and acoustic to enhance hearing and better discrimination of speech. Further, in 2020, scientists developed a 3D-microscaffold cochlear implant using a 3D printed steroid reservoir was designed to reduce the damage of residual hearing against electrode insertion trauma. Cochlear implant manufacturers have to submit information regarding the material used, efficacy based on clinical trials, any adverse effects to the FDA. The manufacturer can begin the sale of the implants in the USA only after receiving approval from the FDA. Major players in the hearing implants devices and equipment market are Sonova (Switzerland), Advanced Bionics AG (Switzerland), Siemens AG, William Demant Holding Group (Denmark), Microson S.A. (Spain), RION, SeboTek Hearing Systems, Arphi Electronics, Widex A/S, and Audina Hearing Instruments. North America was the largest region in the global hearing implants devices and equipment market in 2022. Asia-Pacific was the second-largest region in the hearing implants devices and equipment market. The regions covered in the global hearing implants devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the hearing implants devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, the UK, the USA, and Australia. The hearing implants market consists of sales of cochlear implants, bone anchored hearing aids (BAHA), mid-ear implants, and auditory brainstem implants (ABI) that are used to improve hearing capability. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global hearing implants market is segmented - 1) By Type: Cochlear Implants, Middle Ear Implants, Bone Conduction Implants, Auditory Brainstem Implant 2) By End-User: Hospitals, ENT clinics, Ambulatory Surgical Centres 3) By Age: Adult , Pediatric

The ENT devices are used in the diagnosis and treatment of ear, nose, and throat diseases. The main types of ENT devices are hearing aid devices and equipment, hearing diagnostic devices and equipment, ENT surgical devices and equipment, hearing implants, voice prosthesis devices and equipment, and nasal splints. A hearing aid device is an electronic device that is worn in or behind the ear. It makes sounds louder so that a person with hearing loss can listen, communicate, and participate fully in daily activities. The type of expenditure is public and private. The products used are instruments/equipment and disposables. The various end-users are hospitals and clinics, diagnostic laboratories, and others. The ENT devices market research report is one of a series of new reports from The Business Research Company that provides ENT devices market statistics, including ENT devices industry global market size, regional shares, competitors with an ENT devices market share, detailed ENT devices market segments, market trends and opportunities, and any further data you may need to thrive in the ENT devices industry. This ENT devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global ent devices market grew from $30.21 billion in 2022 to $32.98 billion in 2023 at a compound annual growth rate (CAGR) of 9.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The ent devices market is expected to grow to $45.04 billion in 2027 at a CAGR of 8.1%. Many governments across the world have introduced new healthcare acts and continuously increased healthcare spending. Healthcare coverage and expenditure also increased significantly. In 2021, the Indian government launched Ayushman Bharat PradhanMantri Jan ArogyaYojana (AB-PMJAY) is providing health assurance cover of up to ?5 Lakh per year per family for secondary and tertiary healthcare hospitalizations. Favourable government decisions and increased healthcare spending increased the demand for healthcare services and this drove the demand for ENT devices during this period. Interest rates globally are forecasted to rise in most of the developing and developed economies during the forecast period; this is expected to limit new investments in the market. Most countries across the world are raising interest rates to control inflation and also to limit the flow of capital out of the country. This is likely to affect new investments in terms of expansion, research, and development of new products. For instance, the US interest rates are expected to rise to 3.5% by 2021. These factors are expected to have a negative impact on the market as borrowing money becomes expensive, thereby affecting the market growth. ENT device manufacturers are investing in technologies to develop user-friendly and non-invasive equipment. They are continuously investing funds and resources into R&D to increase the scope of their devices. For instance, Intersect ENT developed Propel Mometasone Furoate Implant (PMFI) to treat chronic sinusitis. It is a bio-absorbable steroid that is placed directly into the sinus mucosa. It controls the release of drugs and dissolves over time. In another breakthrough in sinusitis treatment, SinuSys Corporation received FDA approval for its Vent-Os Sinus Dilation device. It is a small, low-pressure insert that is designed to gently open the sinus ostia and use the body’s natural mucosal fluids to expand the device. Major companies in the ENT devices market include Sonova Holdings AG, William Demant Holdings A/S, Medtronic Inc., GN Store Nord A/S, Cochlear Limited, Olympus Corporation, Stryker Corporation, Karl Storz SE & Co KG, Merck & Co, and Smith & Nephew plc. Asia-Pacific was the largest region in the global ENT devices market in 2022. North America was the second largest region in the global ENT devices market. Africa. was the smallest region in the global ENT devices market. The regions covered in the ENT devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the ENT devices market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The ENT devices market consists of sales of instruments such as Pure tone and impedance audiometers, BERA and OAE screening machines, nerve stimulators, and high-end microdrill that are used for diagnosis and treatment of ENT diseases. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global ent devices market is segmented - 1) By Type: Hearing Aid Devices And Equipment, Hearing Diagnostic Devices And Equipment, ENT Surgical Devices And Equipment, Hearing Implants, Voice Prosthesis Devices And Equipment, Nasal Splints 2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users 3) By Type of Expenditure: Public, Private 4) By Product: Instruments/Equipment, Disposables

3D printed medical devices are artificial devices that replace a missing body part or biological structure and are manufactured by laying successive layers of material using inputs from a digital 3D model. The main types of 3D printed medical devices are implants, surgical instruments, prosthetics, tissue engineering devices, and others. The 3D-printed implants are medical implants that are made using 3D printing technology to create complex geometries. These are made up of raw materials such as plastics, biomaterial inks, and metals and alloys. The technologies involved in 3D printed medical devices are fused deposition modeling, digital light processing, stereolithography, and selective laser melting. These provide applications in orthopedic, spinal, dental, hearing aids, and others that are used by end-users such as hospitals, diagnostics centres, academic institutions, and others. The 3D printed medical devices market research report is one of a series of new reports from The Business Research Company that provides 3D printed medical devices market statistics, including 3D printed medical devices industry global market size, regional shares, competitors with a 3D printed medical devices market share, detailed 3D printed medical devices market segments, market trends and opportunities, and any further data you may need to thrive in the 3D printed medical devices industry. This 3D printed medical devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global 3d printed medical devices market grew from $2.87 billion in 2022 to $3.57 billion in 2023 at a compound annual growth rate (CAGR) of 24.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The 3d printed medical devices market is expected to grow to $9.09 billion in 2027 at a CAGR of 26.3%. The increasing prevalence of osteoarthritis and similar musculoskeletal conditions is one of the major factors driving the growth of the 3D printed medical devices market. Osteoarthritis is a disorder that damages the joint cartilage and surrounding tissues causing pain, stiffness, and loss of joint function to the person affected by it. The 3D printing medical devices enable the creation of a replica of a patient's joint, which can provide surgeons with a crucial piece of information that might not be visible on a 2-dimensional scan. The chance of developing osteoarthritis increases with age. For instance, according to the US National Library of Medicine report, by 2040, it is estimated that approximately 78 million (26%) US adults aged 18 years and above will be projected to have doctor-diagnosed arthritis. Thereby driving the adoption of 3D printed medical devices, positively impacting the market growth. Biocompatibility issues related to 3D printed medical devices restrict the growth of the 3D printed medical devices market. Biocompatibility implies the properties that make a material or a device compatible with the human body. If the material used for the preparation of a 3D printed implant device is not compatible with the patients' biomechanics, then patients may suffer side effects such as abnormal growth of bone and bleeding. Among the most common metal used in the manufacturing of 3D printed medical devices is Titanium. Though Titanium offers reliability and accuracy in creating medical-grade products, some human bodies tend to reject titanium as its chemical composition can inhibit the bone and tissue from interacting with the implant. Apart from these other reasons which may contribute to the failure of metallic implants that are either caused by the material properties of the metal (e.g., high stiffness, high corrosion rate, and toxicity) itself or by the exposure of the bone to infected metal implants i.e., infection. The increasing use of 3D printing technology in the spine industry is one of the latest trends in the 3D printing medical devices market. The spine industry is adopting 3D printing to produce new innovative products that can promote bone ingrowth and improve implant fixation to spine bone, reducing the number of manufacturing steps, thereby making the 3D printing process more cost-effective in several cases. For instance, Medtronic launched its titanium 3D printed platform – TiONIC Technology. TiONIC Technology is a 3D printed technique that uses laser methods to create implants with enhanced surface textures. Artic-L is the first implant created by the company using TiONIC Technology. The implant is made up of titanium and is designed to be used by surgeons in spine surgery. In addition to that, K2M’s Lamellar, introduced its 3D Titanium Technology to create a 3D spinal implant. The 3D printing medical device using titanium technology uses an advanced 3D printing method to create structures that were once considered impractical with traditional manufacturing techniques. The implants use titanium powder and are associated with bone growth activity. Food and Drug Administration (FDA) has a Centre for Device and Radiological Health (CDRH) to regulate the firm which manufacture, repackage, relabel and/or import 3D printing medical devices in the US. FDA provides manufacturers with a draft with guidance that includes recommendations for device design, manufacturing, and testing considerations during the development of 3D printing medical devices. Section F of the 'Technical Considerations for Additive Manufactured Medical Device' draft, requires the manufacturers to evaluate the biocompatibility of the final finished device as described in the guidance "Use of International Standard ISO-10993". The guidelines also require the manufacturer of the 3D printing devices to mention the additional information in the label if any toxic chemical additives such as certain additives, catalysts, binding and curing agents, uncured monomers, and plasticizers are used in making 3D printing medical devices. In July 2020, Medtronic, an American Irish-domiciled medical device company acquired Medicrea International for an undisclosed amount. The acquisition of Medicrea expands Medtronic’s already deep portfolio as this adds to their spinal solution profile as the advent of new digital technology will offer the ability to custom spinal implants. Medicrea International is a spinal surgery company with 30+ FDA-approved spinal implant technologies that have been utilized in over 150,000 spinal surgeries to date. Major players in the 3D printed medical devices market are 3D Systems Corporation, EnvisionTEC, Stratasys Ltd., Arcam AB, Cyfuse Biomedical, Materialise NV, Organovo Holdings, EOS GmbH, FabRx Ltd., and Concept Laser. North America was the largest region in the 3D printed medical devices market in 2022. Western Europe was the second largest region in the global 3D printed medical devices market report. The regions covered in the global 3D printed medical devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the 3D printed medical devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The 3D printed medical devices market consists of sales of 3D printed prosthetics and implants. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global 3D printed medical devices market is segmented - 1) By Type: Implants, Surgical instruments, Prosthetics, Tissue engineering devices, Other Types 2) By Application: Orthopedic, Spinal, Dental, Hearing Aids, Other Applications 3) By Technology: Fused Deposition Modelling, Digital Light Processing, Stereolithography, Selective Laser melting 4) By Raw Material: Plastics, Biomaterial inks, Metals and Alloys 5) By End User: Hospitals, Diagnostics Centres, Academic Institutions, Other End Users

Other health and personal care refer to services for people who require assistance with daily activities and health issues. The other health and personal care include health and personal care products excluding medicines, optical products, perfumes, cosmetics, beauty supplies, and food supplement products in the retail and wholesale industry. The other types of health and personal care stores are convalescent supply stores, prosthetic stores, hearing aid stores, sick room supply stores, medical equipment and supplies stores, and personal mobility scooter dealers. Hearing aid stores refer to an electronic device for amplifying sound that is worn in or behind the ear of a person with hearing loss. The categories included are mass products and premium products. The stores are licensed as branded, brand licensed, and unbranded. The other health and personal care stores market research report is one of a series of new reports from The Business Research Company that provides other health and personal care store market statistics, including other health and personal care store industry global market size, regional shares, competitors with other health and personal care store market share, detailed other health and personal care store market segments, market trends and opportunities, and any further data you may need to thrive in the other health and personal care store industry. This other health and personal care store market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global other health and personal care stores market size will grow from $65.74 billion in 2022 to $68.93 billion in 2023 at a compound annual growth rate (CAGR) of 4.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global other health and personal care stores market size is expected to grow to $79.69 billion in 2027 at a CAGR of 3.7%. There is an increased concentration of growth in the number of surgeries performed worldwide across the historic period. Many people lose their lives from conditions that require surgical care. According to a study published by The Lancet Commissions, if the LMICs were to scale up the surgery rate annually, then a minimum volume of 5000 operations per 100,000 population is expected to be fulfilled by about two-thirds of countries. The increase in the number of surgeries performed annually is expected to boost the market's growth as surgeries will increase the demand for health and personal care products supply. Product recalls in the global supply chain occur due to increasing concern about product safety among consumers. Retailers are the bridge or connection between the upstream supply chain, which includes manufacturers and wholesalers, and consumers. In February 2020, Advanced Bionics LLC (AB), a US subsidiary of Sonova Holding AG—a leading hearing aid provider—voluntarily recalled HiRes Ultra and Ultra 3D cochlear implants for corrective action, and this one-time recall is estimated to cost them $51 million due to issues of reduced performance by the customers. In February 2020, ResMed recalled Stellar 100 and 150 Non-invasive and Invasive Ventilators due to the failure of the device. In a reverse supply chain, a major role is played by the retailers; thus, a product recall has a negative impact on the retailers in terms of revenue. The use of online supply platforms, or e-commerce sites, is gaining increased popularity among retailers and customers as well. Online retailing overcomes the traditional retailing stores in ways like limiting geographical barriers, cost-effective advertising, and marketing channels, creating a market for niche-products, providing customers to compare and shop, remaining open 24/7, creating targeted communication, and more. In November 2021, SMV Healthcare, a Chennai-based pharmaceuticals company, launched MyMedicalShop.com, an online platform for purchasing medicine and healthcare products. E-commerce builds a new path without the need for a manual store for retailers to reach customers. In April 2022, Lifesupply Health Supplies Inc., a Canada-based medical supplies company, acquired Smart Move Medical for an undisclosed amount. The acquisition would expand the distribution network of the company and provide it with broader access to a network of suppliers internationally. Smart Move Medical is a Canada-based medical equipment supplier. Major players in the other health and personal care stores market are USANA Health Sciences Inc., Enzymatic Therapy Inc., Ajinomoto Health and Nutrition North America Inc., Super Supplements Inc., Herbalife Nutrition Ltd., Forever Living Products International, Trivita Inc., Nature's Sunshine Products Inc., ForeverGreen Worldwide, and Integrated Biopharma Inc Asia-Pacific was the largest region in the other health and personal care stores market in 2022. North America was the second-largest region in the global other health and personal care stores market. The regions covered in the global other health and personal care stores market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the other health and personal care stores market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The other health and personal care market includes revenues earned by entities by include medical equipment, diagnostics, hearing aids, personal mobility scooters, prosthetics, and sick room equipment. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global other health and personal care stores market is segmented - 1) By Type: Convalescent Supply Stores, Prosthetic Stores, Hearing Aid Stores, Sick Room Supply Stores, Medical Equipment And Supplies Stores, Personal Mobility Scooter Dealers 2) By Category: Mass Products, Premium Products 3) By License: Branded, Brand Licensed, Unbranded

NVH testing refers to measuring, modifying, and optimizing the noise and vibration characteristics of vehicles by providing noise reduction and quality assurance of interior and exterior noise to reduce noise pollution. Noise, vibration & harshness (NVH) testing is used to enhance comfort, vehicle performance, and brand recognition. The main types of NVH testing are hardware and software. NVH testing hardware equipment provides noise reduction and quality assurance of interior and exterior noise to reduce noise pollution. The different applications are impacted hammer testing and powertrain NVH testing, environmental noise measurement, pass-by noise testing, noise source mapping, sound intensity measurement and sound quality testing, building acoustics, mechanical vibration testing, and product vibration testing and are used in various sectors such as automotive and transportation, aerospace and defense, power generation, consumer electronics, construction, and other end users. The NVH testing market research report is one of a series of new reports from The Business Research Company that provides NVH testing market statistics, including NVH testing industry global market size, regional shares, competitors with a NVH testing market share, detailed NVH testing market segments, market trends and opportunities, and any further data you may need to thrive in the NVH testing industry. This NVH testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global noise, vibration & harshness (NVH) testing market size grew from $1.99 billion in 2022 to $2.09 billion in 2023 at a compound annual growth rate (CAGR) of 5.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The noise, vibration & harshness (NVH) testing market size is expected to grow to $2.57 billion in 2027 at a CAGR of 5.3%. Government regulations to reduce noise pollution are significantly driving the growth of the noise, vibration, and harshness (NVH) testing market. Noise pollution refers to unwanted and long-term noise levels that lead to adverse effects on humans and other wildlife organisms. Noise pollution is hazardous and causes a variety of health issues such as sleep disturbance, hypertension, hearing loss, dementia, psychological dysfunctions, and affects the cardiovascular and metabolic system. Governments are working on policy planning and regulations building globally to control noise pollution and control and optimize noise pollution advanced noise, vibration, and harshness testing products and services are required. For instance, in July 2021, The National Planning Policy Framework was revised by the government of the UK. The National Planning Policy Framework has provisions on noise that demand the local planning policies protection against noise and identifying and protecting existing tranquil environments from noise pollution. Therefore, government regulations to reduce noise pollution are contributing to the growth of the noise, vibration, and harshness (NVH) testing market. Product innovations are the key trends gaining popularity in the noise, vibration, and harshness (NVH) testing market. Major companies operating in the NVH testing sector are focused on developing innovative products for noise, vibration, and harshness (NVH) testing to strengthen their position in the market. For instance, in March 2020, Bruel & Kjaer, a Denmark-based electronics company launched version 2019.1 of NVH Simulator. This NVH Simulator new version will expand the electric and hybrid vehicle's modeling ability and other 200 improvements and enhancements. Using NVH Simulator 2019.1 the tonal harmonics in electric vehicle sound can be extracted from measurement and re-synthesized using the NVH Simulator software in real-time driver-in-the-loop simulations. In November 2021, Woodbridge, a Canada-based privately held investment holding company, acquired Hematite for an undisclosed amount. With this acquisition, Woodbridge is in a position to take advantage of and develop new efficiencies in the development of integrated, multi-functional, and high-value next-generation products for the industry's rapidly expanding new energy vehicles (NEV), while also continuing to provide beneficial internal combustion engine (ICE) solutions. Hematite is a US-based NVH specialist. Major players in the noise, vibration & harshness (NVH) testing market are National Instruments Corporation, Siemens AG, Brüel & Kjær, IMC Test & Measurement GmbH, Signal.X Technologies LLC, GRAS Sound & Vibration, Prosig Ltd., Dewesoft d.o.o., Müller-BBM VibroAkustik Systeme GmbH, ECON Technologies Co. Ltd., Erbessd Instruments, Honeywell International Inc., PCB Piezotronics, and Polytec GmbH. North America was the largest region in the noise, vibration & harshness (NVH) testing market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in noise, vibration & harshness (NVH) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the noise, vibration & harshness (NVH) testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The noise, vibration & harshness (NVH) testing market includes revenues earned by entities by improving the sound and acoustics together with reduced vibration in the automobiles and vehicle parts. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global noise vibration and harshness nvh testing market is segmented - 1) By Type: Hardware, Software 2) By Application: Impact Hammer Testing And Powertrain NVH Testing, Environmental Noise Measurement, Pass-By Noise Testing, Noise Source Mapping, Sound Intensity Measurement and Sound Quality Testing, Building Acoustics, Mechanical Vibration Testing, Product Vibration Testing 3) By End-User: Automotive And Transportation, Aerospace And Defense, Power Generation, Consumer Electronics, Construction, Other End-Users

The industrial noise control market involves the use of methods for reducing noise, such as soundproofing through the use of acoustic materials, acoustic walls, and acoustic panels, among others, to protect the workers in industries from harmful levels of noise. Industrial noise control products and solutions are utilized at industrial sites to control and reduce industrial and commercial noise. The main types of industrial noise control products are flexible, rigid, and vibration isolation. The flexible product refers to the use of flexible industrial noise control solutions such as fabric curtains or sound reduction panels that are made using flexible and lightweight materials and are therefore easy to use. The flexible types of noise control products have high tensile strength and are extremely easy to install. The various material types include polymers and composites, glass, metal, and fiber, which are used in applications such as internal noise control and external noise control. It is employed in manufacturing, construction and mining, healthcare, and other end-users. The industrial noise control research report is one of a series of new reports from The Business Research Company that provides industrial noise control statistics, including functional safety industry global market size, regional shares, competitors with an industrial noise control share, detailed industrial noise control segments, market trends and opportunities, and any further data you may need to thrive in the functional safety industry. This industrial noise control research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global industrial noise control market size grew from $4.87 billion in 2022 to $5.15 billion in 2023 at a compound annual growth rate (CAGR) of 5.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The industrial noise control market size is expected to grow to $6.22 billion in 2027 at a CAGR of 4.9%. The proliferation of the manufacturing sector is expected to propel the growth of the industrial noise control market going forward. The manufacturing sector refers to the industry that engages in the creation or manufacture of goods using equipment, labor, machines, tools, and chemical or biological treatments or formulations. Manufacturers are increasingly relying on industry noise control methods as the manufacturing sector has been consistently growing in recent years. For instance, as per data by the United Nations Industrial Development Organization, there has been an increase of 9.4% in global manufacturing production in 2021. Also, according to the Federal Reserve, a US-based bank, there has been a growth of 4.9% year on year in manufacturing production in the United States as of 2022. Therefore, the proliferating manufacturing sector is driving the growth of the industrial noise control market. Innovations in noise control technology has emerged as the key trend gaining popularity in the industrial noise control market. Major companies operating in the industrial noise control market are focused on the development of innovative technology to strengthen their position in the market. For Instance, in January 2021, Silentium, an Israel-based innovative noise reduction product, and solutions company developed innovative technology to reduce noise in industries and other workplaces. The company developed an innovative tool that uses Active Noise Cancellation (ANC) technology and uses a Silentium ANC software that provides active acoustics simulation. This technology helps reduce noise at the workplace thereby reducing workplace injuries and accidents caused due to noise, reducing noise-induced stress, and improving the overall productivity of employees. The development of this innovative technology by Silentium is another step forward in the industrial noise control market. In January 2022, The Stephens Group, a US-based private investment firm, acquired Kinetics Noise Control Inc for an undisclosed amount. Through this acquisition, the Stephens group would acquire all assets of Kinetics Noise Control, Inc to form a new company called Catalyst Acoustics Group. They offer a wide portfolio of products & solutions for noise control and the Catalyst Acoustics Group serves as a platform for a group of acoustic, seismic, vibration, and noise control companies. Kinetics Noise Control Inc is a US-based manufacturer of innovative noise and vibration control products and solutions. Major players in the industrial noise control market are Sound Seal Inc., Sintesi PLC, Ventac Co. Ltd., Cellofoam GmbH & Co. KG, R. Kohlhauer GmbH, Pyrotek, ArtUSA Industries Inc., KSM Group, Shaver Industries, Merford Holding B.V, REBLOC GmbH, Durr Universal Inc., Bbm Akustik Technologies, Technofirst SA, Stopson Italiana, Total Vibration Solutions Ltd., Kinetics Noise Control Inc., Linder GmbH, CSTI acoustics, and eNoiseControl. Asia-Pacific was the largest region in the industrial noise control market in 2022. The regions covered in the industrial noise control market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the industrial noise control market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The industrial noise control market consists of revenues earned by entities by providing noise control services such as damping. The market value includes the value of related goods sold by the service provider or included within the service offering. The industrial noise control market also includes sales of industrial fan silencers, acoustic louvers, industrial exhaust silencers, noise control enclosures, and duct silencer. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global industrial noise control market is segmented - 1) By Product Type: Flexible, Rigid, Vibration Isolation 2) By Material Type: Polymer and Composite, Glass, Metal, Fabric 3) By Application: Internal Noise Control, External Noise Control 4) By End User: Manufacturing, Construction and Mining, Healthcare, Other End-Users

Medical equipment are devices that can be instrument, apparatus or machine that can be used in the prevention, diagnosis or treatment of illness or disease, or for detecting, measuring, restoring, correcting or modifying the structure or function of the body for health purpose. The main types of medical equipment are in-vitro diagnostics, dental equipment and supplies, ophthalmic devices, diagnostic imaging equipment, cardiovascular devices, hospital supplies, surgical equipment, orthopedic devices, patient monitoring devices, diabetes care devices, nephrology and urology devices, ENT devices, anesthesia and respiratory devices, neurology devices, and wound care devices. In-vitro diagnostics are tests done on samples like blood or tissue that is taken from the human body. In-vitro diagnostics will detect diseases or other conditions and are used to monitor a person’s overall health to cure, treat, or prevent diseases. The type of expenditure involved is public and private. The various product are instruments/equipment and disposables. The various end users involved are hospitals and clinics, homecare, diagnostics centres, and others. The medical equipment market research report is one of a series of new reports from The Business Research Company that provides medical equipment market statistics, including medical equipment industry global market size, regional shares, competitors with a medical equipment market share, detailed medical equipment market segments, market trends and opportunities, and any further data you may need to thrive in the medical equipment industry. This medical equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global medical equipment market grew from $639.75 billion in 2022 to $695.05 billion in 2023 at a compound annual growth rate (CAGR) of 8.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The medical equipment market is expected to grow to $922.39 billion in 2027 at a CAGR of 7.3%. The rise in sedentary jobs, busy lifestyles, and changing consumer preferences are affecting the disease profile of the world population, especially non-communicable diseases such as cancer, diabetes, and cardiovascular diseases. Long working hours, less physical activity, and unhealthy eating and drinking habits are major causes of chronic diseases such as diabetes. According to the World Health Organization, chronic disease prevalence is expected to rise by 57% globally, by the year 2020. This is increasing the demand for medical devices used in the diagnosis, prognosis, and treatment of several diseases, thereby driving the demand for medical equipment. These factors are expected to increase the patient pool globally, thereby driving the market during the forecast period. Regulatory changes are likely to lead to increased costs relating to new product development and service offerings to clients. These changes are related to customer data protection such as the European Union's General Data Protection Regulation (GDPR), changes to equipment approval procedures, and other regulatory changes. For instance, according to cookieyed data 2021, in the US, PwC reported that 68% of 200 businesses surveyed intended to spend between $1 million and $10 million to comply with GDPR regulations. The GDPR regulation is an EU law on data protection and privacy of individuals residing in the European Union and the European Economic Area (EEA). It also regulates the export of personal data outside the EU and EEA areas. Additionally, the FDA is requesting more clinical data to support claims, therefore increasing the time to process 510(k)s by over 55% over the last decade. The potential loss of revenue due to delays in product release and additional costs incurred due to stringent approval processes puts a strain on investments relating to new product development, thereby affecting the growth of the medical equipment market. Device performance and patient data are available to healthcare service providers and are helping them to improve patient monitoring and overall care quality. Some companies are integrating medical device data with EMR (Electronic Medical Records) to improve transparency and collaboration. As consumer wearables are becoming more common, patient data volumes are increasing and companies are investing in deploying data management, warehousing, and security technologies. For example, Medtronic launched a tool to augment their cardiac devices to securely transfer device data to doctors and allow them to monitor the critical health indicators of their patients. Major companies in the medical equipment market include Medtronic Inc., Abbott Laboratories, Johnson & Johnson, Cardinal Health, Inc., Becton Dickinson, Siemens AG, STRYKER CORPORATION, Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd., and Boston Scientific Corporation. North America was the largest region in the global medical equipment market in 2022. Asia-Pacific was the second largest region in the global medical equipment market. The regions covered in the medical equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the medical equipment market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The medical equipment market consists of sales of devices used in the diagnosis, treatment and monitoring of medical conditions. The market includes diagnostic devices, imaging devices, surgical devices and patient monitoring devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global medical equipment market is segmented - 1) By Type: In-Vitro Diagnostics, Dental Equipment And Supplies, Ophthalmic Devices, Diagnostic Imaging Equipment, Cardiovascular Devices, Hospital Supplies, Surgical Equipment, Orthopedic Devices, Patient Monitoring Devices, Diabetes Care Devices, Nephrology And Urology Devices, ENT Devices, Anesthesia And Respiratory Devices, Neurology Devices, Wound Care Devices 2) By Type of Expenditure: Public, Private 3) By Product: Instruments/Equipment, Disposables 4) By End User: Hospitals And Clinics, Homecare, Diagnostics Centers, Other End Users Subsegments Covered: Point-of-Care Diagnostics Devices And Equipment, Immunochemistry Diagnostic Devices And Equipment, Clinical Chemistry Diagnostics Devices And Equipment, Molecular Diagnostics Devices And Equipment, Microbiology Diagnostic Devices And Equipment, Hemostasis Diagnostic Devices And Equipment, Hematology Diagnostic Devices And Equipment, Immunohematology Diagnostic Devices And Equipment, Therapeutic Dental Equipment, General Dental Devices And Equipment, Dental Diagnostic Imaging Devices And Equipment, Dental Surgical Devices And Equipment, Vision Care Devices And Equipment, Cataract Surgery Devices And Equipment, Refractive Surgery Devices And Equipment, Diagnostic And Monitoring Ophthalmic Devices And Equipment, X-Ray Systems Devices And Equipment, Ultrasound Systems Devices And Equipment, Computed Tomography (CT) Scanners Devices And Equipment, Magnetic Resonance Imaging Systems Devices And Equipment, Cardiovascular Monitoring And Diagnostic Devices And Equipment, Nuclear Imaging Devices And Equipment, Cardiovascular Surgery Devices And Equipment, Cardiac Rhythm Management (CRM) Devices And Equipment, Interventional Cardiology Devices And Equipment, Defibrillator Devices And Equipment, Peripheral Vascular Devices And Equipment, Prosthetic Heart Valve Devices And Equipment, Electrophysiology Devices And Equipment, Cardiac Assist Devices And Equipment, Disposable Hospital Supplies, Sterilization Equipment And Disinfectants, Mobility Aids And Transportation Equipment, Operating Room Equipment, Surgical Sutures And Staples, Handheld Surgical Devices And Equipment, Electrosurgical Devices And Equipment, Joint Reconstruction Devices And Equipment, Spinal Surgery Devices And Equipment, Trauma Fixation Devices And Equipment, Orthobiologics Devices And Equipment, Arthroscopy Devices And Equipment, Orthopedic Braces And Support Devices And Equipment, Craniomaxillofacial (CMF) Devices And Equipment, Orthopedic Prosthetics, Orthopedic Accessories,, Fetal And Neonatal Monitoring Devices, Weight Monitoring And Body Temperature Monitoring Devices And Equipment, Vital Parameter Monitoring Devices And Equipment, Remote Patient Monitoring Devices And Equipment, Blood Glucose Test Strips, Insulin Pens, Syringes, Pumps And Injectors, Lancing Devices And Equipment, Continuous Glucose Monitoring Devices And Equipment, Blood Glucose Meters, Dialysis Devices And Equipment, Urinary Stone Treatment Devices And Equipment, Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment, Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment, Endoscopy Devices And Equipment, Hearing Aid Devices And Equipment, Hearing Diagnostic Devices And Equipment, ENT Surgical Devices And Equipment, Hearing Implants, Voice Prosthesis Devices And Equipment, Nasal Splints, Respiratory Devices And Equipment (Therapeutic And Diagnostic), Anesthesia Machines, Anesthesia Disposables, Respiratory Disposables, Cerebrospinal Fluid Management (CSF) Devices And Equipment, Interventional Neurology Devices And Equipment, Neurosurgery Devices And Equipment, Neurostimulation Devices, Traditional Adhesive Dressings, Negative-pressure Wound Therapy (NPWT), Traditional Gauze Dressings, Advanced Wound Care Devices